Mutations in CHEK2 Associated with Prostate Cancer Risk
- 1 February 2003
- journal article
- research article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 72 (2), 270-280
- https://doi.org/10.1086/346094
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Structural and Functional Versatility of the FHA Domain in DNA-Damage Signaling by the Tumor Suppressor Kinase Chk2Molecular Cell, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Germline mutations in the ribonuclease L gene in families showing linkage with HPC1Nature Genetics, 2002
- Evaluation of Candidate Genes in Case-Control Studies: A Statistical Method to Account for Related SubjectsAmerican Journal of Human Genetics, 2001
- Evaluation of Linkage and Association of HPC2/ELAC2 in Patients with Familial or Sporadic Prostate CancerAmerican Journal of Human Genetics, 2001
- Genetics of Prostate Cancer: Too Many Loci, Too Few GenesAmerican Journal of Human Genetics, 2000
- Association of HPC2/ELAC2 Genotypes and Prostate CancerAmerican Journal of Human Genetics, 2000
- Genomic instability-based transgenic models of prostate cancerCarcinogenesis: Integrative Cancer Research, 2000
- Evidence for a Prostate Cancer–Susceptibility Locus on Chromosome 20American Journal of Human Genetics, 2000
- Regulation of RAD53 by the ATM -Like Kinases MEC1 and TEL1 in Yeast Cell Cycle Checkpoint PathwaysScience, 1996